Atlas Trials

Standard Infusion Carboplatin Versus Prophylactic Extended Infusion Carboplatin in Patients With Patients With Recurrent, Ovary, Fallopian Tube, and Primary Peritoneal Cancer

Clinical trial NCT01248962 · COMPLETED

Trial details

NCT number
NCT01248962
Sponsor
Memorial Sloan Kettering Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Ovarian CancerFallopian Tube CancerPeritoneal Cancer
Start date
2010-11-01
Primary completion
2018-08-01
Enrollment
146

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.